Navigation auf uzh.ch
Navigation auf uzh.ch
Over 20 participants responded to the call «Are you motivated to make a positive social impact?» and worked in interdisciplinary groups to develop digital solutions to current issues.
The 4th UZH Healthy Longevity Innovation Days will focus on «Core Technologies for Healthy Longevity Innovation».
Oncobit, founded in 2018 as a UZH spin-off, announces partnership with Immunocore to advance therapy response analysis in clinical trials.
The UZH Life Science Fund awards CHF 1 million for FimmCyte.
Which wall will your research break? Pitch your innovative idea in just 3 minutes, showcasing a breakthrough that creates a positive impact on science and society. For Students and early career researchers of all disciplines.
Interview with Josua Jordi, CEO and co-founder of EraCal at the Innovator Mornings
The Deputy Head Innovation Office at the University of Zurich, Eva Maria Håkanson talks on the Swissnex San Francisco Podcast about moving ideas from the university to market.
The Innovation Booster “Sustainable Digital Finance” aims to accelerate radical innovations that foster sustainability in the financial industry by harnessing technology. The University of Zürich is the leading house for this InnoBooster.
The Vice-Rector for Research, Prof. Elisabeth Stark awarded certificates to Simon Bredl, Simon Gruening and Kevin Yim for their successful completion of the UZH Entrepreneur Fellowship program in 2023.
Congratulations to UZH spin-off EraCal Therapeutics to their new partnering deal with Novo Nordisk. This is a huge step foward for the start-up, with a potential value of EUR 235 million, and brings revolutionary therapy for obesity one step closer to the market.
The 1st Founder Call by DIZH enables projects from the idea to the proof of concept that aim to establish a start-up or spin-off. Ten projects were recently approved: Get an insight into the six convincing projects by UZH Researchers.
The hands-on innovation course format offers a unique opportunity to enhance students personal and professional growth. One team impressed the jury with the most developed solution towards the challenge proposed and won not only the jury prize for the best concept but also the audience prize.
UZH researchers have co-founded Seito Biologics AG to develop a new treatment for autoimmunty. After several years of research at the Department of Immunology of the University of Zurich, the team is now ready to take the next step with their approach, which is based on selective Treg cell engagers (TREX).
UZH researchers are invited honoring excellent research ventures and celebrating their successes.
How do I set up an innovation project and get funding from Innosuisse? Advice from experts at a recent event.
The Hans Eggenberger Foundation has extended its financial support for the UZH Entrepreneur Fellowship Program for another three years.
Government, academic and business leaders from Japan and Switzerland gathered at the Switzerland-Japan Economic Forum 2023 in Tokyo to explore the critical role of innovation promotion. UZH Vice President Christian Schwarzenegger shared his expertise on the Swiss ecosystem and the UZH Innovation Hub, a platform for innovation and entrepreneurship at Switzerland’s largest university
In a collaborative project funded by Innosuisse and Enzian Pharmaceutics, scientists at Enzian Pharmaceutics and the University of Zurich (UZH) have reached an important milestone in the development of a new gastroretentive dosage form.
Arcton, a UZH startup and Zurich-based fintech startup founded in 2022, disrupts the Swiss crowdfunding scene with its innovative investing platform. Crowd investing in Switzerland has experienced a significant surge in popularity, with platforms primarily focused on capital raising.
As part of the UZH Entrepreneur Fellowships and the UZH Innovation Grants programs, the UZH Innovation Office has launched a brand new event series "Innovator Mornings".
Venture Kick awarded CHF 150’000 to metaLead, a BioTech UZH Spinoff project, which is developing next-gen antidotes against toxic metals.
CSS and EPFL Innovation Park announced last week the innovation projects that have been selected in their Future of Health (FoHG) program.
Research collaboration between EraCal Therapeutics and Nestlé Health Science
The Novartis Institutes for BioMedical Research (NIBR) is seeking to advance science through the NIBR Global Scholars Program (NGSP). This competitive program supports projects focused on novel science with the objective of being translated to drug discovery and/or clinical research. Magdalini Polymenidou has been selected for the NGSP 2022 and will receive up to 1 mil USD funding over three years along with scientific expertise from NIBR collaborators.
Two new UZH spin-offs join ESA BIC Switzerland, the Swiss Space Incubator!
Prometheus AG wins the Orbital Reef Starter Innovation Challenge.
SignMax is the winner of the Digital Entrepreneurship Bootcamp 2022 edition.
PayMate is the winner team of the UZH Innovathon: Building a human-centered Future of Work.
Former UZH MedTech Entrepreneur fellow David Gage and aiEndoscopic won the Swiss Innovation Challenge 2022.
UZH Entrepreneur Fellow Merens Derungs and his startup Arcton were among the illustrious circle of 6 startups that were allowed to present themselves at the Startup Nights in Winterthur.
The UZH spin-off Navignostics raises CHF 7.5M in a seed financing round to advance precision cancer medicine through spatial single-cell proteomics.
Former MedTech UZH Entrepreneur fellow Dr. Deana Mohr and her company Muvon Therapeutics announce first patient enrolled in phase II clinical study.
Im UZH Innovation Office übernimmst Du administrative und operative Aufgaben zur Unterstützung der verschiedener Aktivitäten im UZH Innovation Hub. Es wartet eine vielseitige und verantwortungsvolle Einstiegsposition in einem dynamischen Umfeld auf Dich.
Former MedTech UZH Entrepreneur fellow Dr. Prajwal and his company Clemedi release Tuberculini, a molecular test for drug-resistant tuberculosis.
Molecular biologist and former UZH Entrepreneur Fellow Ana Montalban-Arques has made a discovery that could cure colon cancer.
InCephalo AG receives EIT Health Gold Track grant
"Engineer the future as an entrepreneur? Why not?" - that was the theme of this year's Credit Suisse Entrepreneurs' Conference. The inspiring panel discussions and keynote speeches also featured entrepreneurial researchers from the University of Zurich.
The UZH Innovation Hub is partnering with Talent Kick, a program where students have the opportunity to form interdisciplinary cross-university co-founder teams and benefit from hands-on entrepreneurial experience during studies.
The University of Zurich with Dr. Sarah Ebling in the lead, has been granted funding for a large innovation project to break communication barriers for better social inclusion. The Swiss Innovation Agency (Innosuisse) has granted CHF 12.4 Mio for this four-year flagship project entitled “Inclusive Information and Communication Technologies” (IICT).
The active ingredient aducanumab, which was discovered at the University of Zurich, has been approved for use in the United States as a treatment for Alzheimer’s disease. Aducanumab, a human antibody, is the first treatment to slow down incurable Alzheimer's disease.
In a facilitated five day innovation sprint students and researchers from three universities will work together to develop, prototype and test new ideas with a focus on sustainability and impact based on the SDGs.
Molecular Partners announced their collaboration with Novartis on potential medicines for use against COVID-19. Molecular Partners will be responsible for Phase 1 and 2 trials for its two therapeutic candidates. If the trials are successful, Novartis will be responsible for further development, manufacturing, and global commercialization.
The majority of the spin-offs founded at the UZH are active in the fields of biotech and medicine. At the UZH Innovation Hub we support research projects in four innovation areas, including biotech and life sciences.
Do you have a voluntary, social enterprise or environmental project that you would like to scale up, develop, and build? Are you looking for additional support and resources to grow your reach? Then U21 RISE is for you.
Kick off your digital business idea with the help of experienced tech founders and experts. Apply now for the Digital Entrepreneurship: Bootcamp!
Find and meet the perfect match thanks to the Futurepreneuship’s “Young professional program” !
Find and meet the perfect match thanks to the Futurepreneuship’s “Young professional program” !
EraCal Therapeutics, a spin-off from the University of Zurich and Harvard University, developed a new drug candidate for obesity and is now a finalist for The Spinoff Prize.
Dave Gage and his team won the final pitch in the Innosuisse Business Concept Course. With aiEndoscopic they are developing an intubation aid for emergency physicians and anesthetists.
You can find all of the latests news and events related to innovation and entrepreneurship at the University of Zurich here.
Read further for information about the latest technologies and licensing opportunities for industry and business partners.
